Illumina

ILMN · NASDAQ

$267.93+$5.27 (+2.01%)TodayMarket closed ·
Prev close $262.66

News sentiment

Tone of recent coverage

Social media sentiment, last 30 days

Average tone of posts mentioning ILMN, from −1 (all negative) to +1 (all positive). Latest day: +0.00 across 29 mentions.

Latest news

  • Press releasePRNewswire

    Illumina To Webcast Upcoming Investor Conference

  • Press releasePRNewswire

    Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs

  • Press releasePRNewswire

    Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026

  • Press releasePRNewswire

    Illumina releases SpliceAI2 to help advance rare disease research

  • News

    Illumina Reports Q2 2026 Results: Full Earnings Call Transcript

  • NewsAvi Kapoor

    LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday

  • NewsPiero Cingari

    10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today

  • Press releasePRNewswire

    Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

  • Press releaseGlobe Newswire

    The Market Just Told You Which Layer Of AI Biology It Is Paying For

  • NewsPiero Cingari

    Bessent's Bond Rescue Fizzles, Walmart Craters 9%: Stock Market Today

  • Press releasePRNewswire

    Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026

  • NewsChandrima Sanyal

    New AI ETF Bets on Healthcare's $9 Trillion Opportunity

  • Press releasePRNewswire

    Illumina expands Billion Cell Atlas program with new AI drug developers

  • Press releasePRNewswire

    Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026

  • Press releasePRNewswire

    Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer

  • Press releasePRNewswire

    Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors

  • Press releaseBusiness Wire

    IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist

  • Press releasePRNewswire

    Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution

  • Press releaseBusiness Wire

    Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights

  • Press releasePRNewswire

    Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research

  • Press releasePRNewswire

    Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research

  • Press releasePRNewswire

    David P. King elected to Illumina's Board of Directors

  • Press releasePRNewswire

    Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact

  • NewsErica Kollmann

    Trump Lands In China With $16 Trillion Of CEO Power — And One Big Ask For Xi

  • NewsAvi Kapoor

    Uber, Exxon Mobil, Illumina, Diamondback Energy: CNBC's 'Final Trades'

  • Press releasePRNewswire

    Illumina Reports Financial Results for First Quarter of Fiscal Year 2026

  • Press releasePRNewswire

    DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows

  • Press releasePRNewswire

    Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease

  • Press releasePRNewswire

    Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026

  • Press releasePRNewswire

    Illumina Announces Changes to Board of Directors

  • Press releasePRNewswire

    Illumina and Labcorp expand collaboration to broaden access to precision oncology testing

  • Press releasePRNewswire

    Illumina advances preventive genomics through strategic consortium with Veritas Genetics

  • News

    Earnings Scheduled For February 5, 2026

  • NewsAvi Kapoor

    Dow Falls Over 100 Points; Amazon Posts Upbeat Q3 Results

  • NewsAvi Kapoor

    Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday

  • NewsSurbhi Jain

    Icahn Hedge Fund's Q2 Moves: Centuri Stake Soars, JetBlue Held, 2 Positions Exited

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.